<DOC>
<DOCNO>EP-0618965</DOCNO> 
<TEXT>
<INVENTION-TITLE>
METHOD FOR GENERATING STRUCTURAL AND FUNCTIONAL DIVERSITY IN A PEPTIDE SEQUENCE
</INVENTION-TITLE>
<CLASSIFICATIONS>C12N1585	A61K39395	C07K1447	C12N900	A61K3800	C12N900	C07K1600	C12N1554	C07K14435	C12N1509	C12N1512	C12N912	C07K1600	C12N1512	C12N1554	A61K3800	C12N1510	C12N1509	A61K39395	C12N1585	C12N1510	C12N912	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C12N	A61K	C07K	C12N	A61K	C12N	C07K	C12N	C07K	C12N	C12N	C12N	C07K	C12N	C12N	A61K	C12N	C12N	A61K	C12N	C12N	C12N	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C12N15	A61K39	C07K14	C12N9	A61K38	C12N9	C07K16	C12N15	C07K14	C12N15	C12N15	C12N9	C07K16	C12N15	C12N15	A61K38	C12N15	C12N15	A61K39	C12N15	C12N15	C12N9	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
<APPLICANT-NAME>
PASTEUR INSTITUT
</APPLICANT-NAME>
<APPLICANT-NAME>
INSTITUT PASTEUR
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
DOYEN NOELLE
</INVENTOR-NAME>
<INVENTOR-NAME>
KALLENBACH SACHA
</INVENTOR-NAME>
<INVENTOR-NAME>
ROUGEON FRANCOIS
</INVENTOR-NAME>
<INVENTOR-NAME>
DOYEN, NOELLE
</INVENTOR-NAME>
<INVENTOR-NAME>
KALLENBACH, SACHA
</INVENTOR-NAME>
<INVENTOR-NAME>
ROUGEON, FRANCOIS
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
A composition containing previously purified nucleotide sequences carrying the Rag-1 and Rag-2 genes and the gene encoding the TdT.
A composition according to claim 1, 
characterized in that
 the previously purified nucleotide sequences are carried on vectors.
A composition comprising the pBlueRec, p Rag-1, p Rag-2 and pMTDT plasmids deposited with the CNCM under the no. I-1160.
A composition containing in combination the previously purified expression products of the Rag-1 and Rag-2 genes and the terminal deoxynucleotidyl transferase.
A method for generating a structural or structural and functional diversity in a peptide sequence by random deletions or insertions of nucleotides in a nucleotide sequence encoding this peptide sequence, said method comprising the transfection of a cell preparation by one or more expression vectors of the Rag-1, Rag-2 gene products and the terminal deoxynucleotidyl transferase (TdT) and by an identical or different vector carrying said nucleotide sequence flanked on either side by one or more RSS recombination sequences.
A method for generating a structural or structural and functional diversity in a peptide sequence by random deletions or insertions of nucleotides in a nucleotide sequence encoding this peptide sequence, said method comprising the transfection of a cell preparation by a vector carrying said nucleotide sequence flanked on either side by one or more RSS recombination sequences, and then in a second step, by one or more identical or different vectors for expressing Rag-1, Rag-2 gene products and the terminal deoxynucleotidyl transferase.
A method according to one of claims 5 to 6, 
characterized in that
 the recombinant vector(s) carrying the nucleotide sequence corresponding to the peptide sequence are transferred in bacteria in order to select the proteins having the desired structure and/or function.
A method according to one of claims 5 to 7 for obtaining immunoglobulins and notably antibodies having a high structural and functional diversity by separated rearrangement of the light and heavy chains and co-expression of both chains.
A method according to one of claims 5 to 7 for obtaining lymphoid cell and particularly T cell receptors having a high structural and functional diversity by rearranging the alpha, beta, gamma and/or delta chains of the T cell receptors.
A method according to claim 8, 
characterized in that
 the rearrangement of the heavy chains is carried out in the presence of the nucleotide sequences of Rag-1, Rag-2 genes and the terminal deoxynucleotidyl transferase gene, said sequences being actually expressed.
A method according to one of claims 5 and 6, comprising the steps of:

a) transfecting a cell preparation by one or more vectors carrying a nucleotide sequence encoding the peptide sequence the variability of which is wanted to obtain and by one or more identical or different vectors for expressing the Rag-1, Rag-2 and TdT genes;
b) isolating the DNA of the cell preparation vectors;
c) removing the vectors which have not undergone any recombination;
d) transforming cell hosts by the vectors which have undergone a recombination resulting from step c), and
e) selecting the cell hosts expressing the molecules with the desired structure and/or function.
A method according to claim 11, 
characterized in that
 said peptide sequence is an alpha, beta, delta or gamma chain of the lymphoid cell receptors or a fragment thereof or a derivative thereof.
A method according to one of claims 8 and 10, comprising the steps of:

a) co-transfecting a cell preparation by one or more vectors carrying nucleotide sequences encoding unrearranged light chains and by one or more vectors expressing the Rag-1 and Rag-2 genes, and
b) co-transfecting another cell preparation by one or more vectors carrying nucleotide sequences encoding unrearranged heavy chains and by one or more vectors expressing the terminal deoxynucleotidyl transferase gene as well as the Rag-1 and Rag-2 genes;
c) isolating the vector DNA from both cell preparations;
d) removing the vectors which have not undergone any recombination,
e) transforming at least two bacterial cultures respectively by the two preparations obtained in step d), amplifying and preparing the DNAs of the bacterial vectors,
f) placing on the same vector genes encoding the heavy and light chains,
g) transforming cell hosts by the vector obtained in step f), and
h) selecting the cell hosts expressing complete immunoglobulin molecules.
A method according to claim 13, 
characterized in that
 the vectors obtained in step c) and which have not undergone any recombination are removed by enzymatic digestion.
A method according to claim 13, 
characterized in that
 the cell preparations are fibroblasts or any other eukaryotic cell.
A method according to claim 13, 
characterized in that
 the vector expressing the terminal deoxyribonucleotidyl transferase is the pMTdT plasmid carrying the terminal deoxyribonucleotide transferase gene
 deposited with the Collection Nationale de Cultures de Microorganismes under the no. I-1160.
</CLAIMS>
</TEXT>
</DOC>
